P. Foa

1.1k total citations
26 papers, 507 citations indexed

About

P. Foa is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Hematology. According to data from OpenAlex, P. Foa has authored 26 papers receiving a total of 507 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 11 papers in Oncology and 7 papers in Hematology. Recurrent topics in P. Foa's work include Lung Cancer Treatments and Mutations (6 papers), Head and Neck Cancer Studies (4 papers) and Cancer Genomics and Diagnostics (3 papers). P. Foa is often cited by papers focused on Lung Cancer Treatments and Mutations (6 papers), Head and Neck Cancer Studies (4 papers) and Cancer Genomics and Diagnostics (3 papers). P. Foa collaborates with scholars based in Italy, France and United States. P. Foa's co-authors include Daris Ferrari, Anna Teresa Maiolo, Andrea Luciani, S. Zonato, E. Polli, L Villa, A. Gabbas, Lionello Camba, Benedetto Comotti and E. Di Bona and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and European Journal of Cancer.

In The Last Decade

P. Foa

21 papers receiving 481 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
P. Foa Italy	13	244	181	149	138	65	26	507
T. Girinsky France	12	250 1.0×	182 1.0×	99 0.7×	90 0.7×	59 0.9×	22	574
Loredana Costa Italy	11	176 0.7×	64 0.4×	124 0.8×	202 1.5×	69 1.1×	29	496
Richard Lizambri United States	10	179 0.7×	162 0.9×	50 0.3×	320 2.3×	39 0.6×	16	521
Hua‐Ling Tsai United States	11	140 0.6×	176 1.0×	108 0.7×	97 0.7×	25 0.4×	44	494
Cih‐En Huang Taiwan	14	96 0.4×	112 0.6×	130 0.9×	121 0.9×	95 1.5×	45	452
Jairam Krishnamurthy United States	12	236 1.0×	79 0.4×	66 0.4×	119 0.9×	69 1.1×	37	423
Tanja Pelz Germany	10	157 0.6×	44 0.2×	92 0.6×	152 1.1×	36 0.6×	16	562
David Thomson United Kingdom	13	197 0.8×	117 0.6×	192 1.3×	157 1.1×	8 0.1×	41	569
Francesco Paolo Caronia Italy	14	73 0.3×	151 0.8×	182 1.2×	230 1.7×	80 1.2×	78	577
Süheyla Serdengeçti Türkiye	14	165 0.7×	30 0.2×	101 0.7×	97 0.7×	17 0.3×	42	449

Countries citing papers authored by P. Foa

Since Specialization

Citations

This map shows the geographic impact of P. Foa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Foa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Foa more than expected).

Fields of papers citing papers by P. Foa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Foa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Foa. The network helps show where P. Foa may publish in the future.

Co-authorship network of co-authors of P. Foa

This figure shows the co-authorship network connecting the top 25 collaborators of P. Foa. A scholar is included among the top collaborators of P. Foa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Foa. P. Foa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Foa, P., et al.. (2020). Hemorrhagic Complications in Patients Treated With Azacitidine and Direct Oral Anticoagulants. American Journal of Therapeutics. 28(4). e503–e504. 1 indexed citations

Ferrari, Daris, Carla Codecà, Maria Di Blasi, et al.. (2016). Radiotherapy and cetuximab for elderly patients affected by loco-regionally advanced head and neck cancer. Annals of Oncology. 27. iv88–iv88.

Santoro, Armando, Vittorio Gebbia, Tiziana Pressiani, et al.. (2014). A randomized, multicenter, phase II study of vandetanib monotherapy versus vandetanib in combination with gemcitabine versus gemcitabine plus placebo in subjects with advanced biliary tract cancer: the VanGogh study. Annals of Oncology. 26(3). 542–547. 86 indexed citations

Luciani, Andrea, Lorenzo Dottorini, Nicolò Matteo Luca Battisti, et al.. (2012). Screening elderly cancer patients for disabilities: evaluation of study of osteoporotic fractures (SOF) index and comprehensive geriatric assessment (CGA). Annals of Oncology. 24(2). 469–474. 20 indexed citations

Luciani, Andrea, Paul B. Jacobsen, Martine Extermann, et al.. (2012). The impact of fatigue and anemia on functional status in older cancer patients treated with chemotherapy. Journal of Geriatric Oncology. 3(3). 182–188. 9 indexed citations

Alongi, Filippo, Mario Bignardi, I. Garassino, et al.. (2011). Prospective phase II trial of cetuximab plus VMAT-SIB in locally advanced head and neck squamous cell carcinoma. Strahlentherapie und Onkologie. 188(1). 49–55. 30 indexed citations

Pressiani, Tiziana, Lorenza Rimassa, C. Boni, et al.. (2011). Phase II randomized trial on dose-escalated sorafenib (S) versus best supportive care (BSC) in patients with advanced hepatocellular carcinoma (HCC) with disease progression on prior S treatment.. Journal of Clinical Oncology. 29(15_suppl). 4115–4115. 8 indexed citations

Luciani, Andrea, Tiziana Ascione, Elena Di Gennaro, et al.. (2009). Dose intensity correlate with survival in elderly patients treated with chemotherapy for advanced non-small cell lung cancer. Lung Cancer. 66(1). 94–96. 32 indexed citations

Давиденко, Ірина, Eric Winquist, Lisa Licitra, et al.. (2009). 8514 SPECTRUM, a phase III trial for patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (SCCHN) receiving chemotherapy with or without panitumumab: interim pooled safety analysis. European Journal of Cancer Supplements. 7(2). 474–475.

10.

Nolè, Franco, Diana Crivellari, Rodolfo Mattioli, et al.. (2009). Phase II study of an all-oral combination of vinorelbine with capecitabine in patients with metastatic breast cancer. Cancer Chemotherapy and Pharmacology. 64(4). 673–680. 29 indexed citations

11.

Luciani, Alain, Tiziana Ascione, Giuseppe Colloca, et al.. (2009). P96 The impact of chemotherapy on body composition and functional status in elderly cancer patients. Critical Reviews in Oncology/Hematology. 72(1). S52–S53. 1 indexed citations

12.

Luciani, Andrea, Tiziana Ascione, S. Caldiera, et al.. (2008). Clinical analysis of multiple primary malignancies in the elderly. Medical Oncology. 26(1). 27–31. 23 indexed citations

13.

Ferrari, Daris, F. Chiesa, Carla Codecà, et al.. (2008). Locoregionally Advanced Nasopharyngeal Carcinoma: Induction Chemotherapy with Cisplatin and 5-Fluorouracil Followed by Radiotherapy and Concurrent Cisplatin. Oncology. 74(3-4). 158–166. 18 indexed citations

14.

Nolè, Franco, Chiara Catania, Rodolfo Mattioli, et al.. (2007). 2114 POSTER Phase II study of an all-oral regimen combining oral vinorelbine with capecitabine as first-line chemotherapy (CT) of metastatic breast cancer (MBC). European Journal of Cancer Supplements. 5(4). 218–218. 3 indexed citations

15.

Nolè, Franco, Chiara Catania, Rodolfo Mattioli, et al.. (2006). Phase II study with dose finding of Oral Vinorelbine in combination with Capecitabine as first-line chemotherapy of Metastatic Breast Cancer (MBC): Preliminary results of the phase II part of the study. European Journal of Cancer Supplements. 4(2). 167–167.

16.

Cascinu, Stefano, Roberto Labianca, Vincenzo Catalano, et al.. (2003). Weekly gemcitabine and cisplatin chemotherapy: a well-tolerated but ineffective chemotherapeutic regimen in advanced pancreatic cancer patients. A report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD). Annals of Oncology. 14(2). 205–208. 22 indexed citations

17.

Bona, E. Di, Francesco Rodeghiero, Benedetto Bruno, et al.. (1999). Rabbit antithymocyte globulin (r‐ATG) plus cyclosporine and granulocyte colony stimulating factor is an effective treatment for aplastic anaemia patients unresponsive to a first course of intensive immunosuppressive therapy. British Journal of Haematology. 107(2). 330–334. 123 indexed citations

18.

Foa, P., Mauro Pomati, S. Caldiera, et al.. (1996). Fluorescence in situ hybridization (FISH) for evaluating residual disease in Philadelphia chromosome-positive chronic myeloid leukemia during interferon alpha therapy. Oncology Reports. 3(5). 847–9.

19.

Foa, P., Alessandra Iurlo, Giuseppe Saglio, et al.. (1991). CHRONIC NEUTROPHILIC LEUKAEMIA ASSOCIATED WITH POLYCYTHEMIA VERA: PATHOGENETIC IMPLICATIONS AND THERAPEUTIC APPROACH. British Journal of Haematology. 78(2). 286–288. 18 indexed citations

20.

Lu, Li, P. Foa, Francesco Chillemi, et al.. (1989). Suppressive biological activity of a synthetic pentapeptide on highly enriched human and murine marrow hematopoietic progenitors: synergism with recombinant human tumor necrosis factor-alpha and interferon-gamma.. PubMed. 17(9). 935–41. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact